A important advancement in diabetes treatment is emerging with the introduction of tirzepatide at a dosage of 45mg. This innovative version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, https://imogenxqek685791.answerblogs.com/41241139/revolutionary-approach-tirzepatide-45mg-for-glucose-management